Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$7500
Buy Report View Sample

Published: October 25, 2023 Report Code: GDME626MM-ST

Select Item

Diabetes Assays Market Report Overview

The diabetes assay market size was valued at $564.6 million in 2023 and is expected to grow at a CAGR of more than 1% during 2023-2033. Diabetes Assays are tests to diagnose diabetes and assess the risk of diabetes, such as pre-diabetes, through analysis of blood.

Diabetes Assays Market Overview, 2023-2033 ($ Million)
Diabetes Assays Market Overview, 2023-2033 ($ Million)
Buy the Full Report for More Insights on the Diabetes Assays Market Forecast
Download a Free Report Sample

The Diabetes Assays market research report explains the market behavior, which will help identify quantitative market trends within the In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on the Diabetes Assays market for the year 2020 and beyond. Furthermore, the report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.

Market Size (2023) $564.6 million
CAGR (2023-2033) >1%
Key Regions ·       North America

·       Europe

·       Asia Pacific

·       South Central America

·       Middle East and Africa
Key Segments ·       Glycated Hemoglobin (HbA1c) Point of care (POC) Assay

·       Glycated Hemoglobin (HbA1c) Lab Assay

·       C-Peptide Assay

·       Fasting Glucose Assay

·       Insulin Assay
Leading Companies ·       Siemens Healthineers AG

·       Abbott Laboratories

·       Roche Diagnostics International Ltd

·       Bio-Rad Laboratories Inc

·       Quidel Corp
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Diabetes Assays Market Dynamics

As per various reports, it has been observed that a substantial proportion of diabetes patients remain undiagnosed and/or untreated.

GlobalData expects that the market for diabetes assays will grow in Europe, North America, and the Asia Pacific (APAC) regions during the forecast period, with the strongest growth being observed in North America. This growth can be attributed to the increasing prevalence of diabetes in North America, while diabetes incidence rates are growing in Europe and APAC. Additionally, many APAC countries have large patient populations and improving healthcare systems, which is expected to intensify growth in these markets.

Diabetes Assays Market Segmentation by Regions

The key regions in the diabetes assays market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. North America led the diabetes assays market share in 2023. The North American diabetes assays market will grow during the forecast period, primarily due to increases in the incidence and prevalence of diabetes. Furthermore, factors such as rising awareness regarding diabetes care, the growing prevalence of obesity, and technological advancements are expected to drive market growth during the projected period.

Diabetes Assays Market Analysis by Regions, 2023 (%)
Diabetes Assays Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Insights on the Regions in the Diabetes Assays Market
Download a Free Report Sample

Diabetes Assays Market Segments

The segments of diabetes assays are Glycated Hemoglobin (HbA1c) Lab Assay, Glycated Hemoglobin (HbA1c) Point of Care (POC) Assay, C-peptide assay, fasting glucose assay, and insulin assay. Glycated Hemoglobin (HbA1c) Lab Assay had the highest market share in 2023.

Diabetes Assays Market Analysis by Segments, 2023 (%)
Diabetes Assays Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Insights on the Segments in the Diabetes Assays Market
Download a Free Report Sample

Diabetes Assays Market - Competitive Landscape

A few of the leading companies in the diabetes assay market are:

  • Siemens Healthineers AG
  • Abbott Laboratories
  • Beckman Coulter Inc + Radiometer Medical ApS
  • Bio-Rad Laboratories Inc
  • DiaSorin SpA
  • Quidel Corp

Siemens Healthineers AG had the highest diabetes assay market share in 2023. It was followed by Abbott Laboratories.

Diabetes Assays Market Analysis by Companies, 2023 (%)
Diabetes Assays Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Insights on the Companies in the Diabetes Assays Market
Download a Free Report Sample

Key Segments Covered in this Report

Diabetes Assays Segments Outlook (Value, $ Million, 2015-2033)

  • Glycated Hemoglobin (HbA1c) Lab Assay
  • Glycated Hemoglobin (HbA1c) Point of care (POC) Assay
  • C-Peptide Assay
  • Fasting Glucose Assay
  • Insulin Assay

Diabetes Assays Regional Outlook (Value, $ Million, 2015-2033)

  • North America
  • Europe
  • Asia Pacific
  • South Central America
  • Middle East and Africa

Key Inclusions

Currently marketed Diabetes Assays and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total Diabetes Assays market revenue by segment and market outlooks from 2015-2033.
  • Market-level data on units, average selling prices, and market values.

Global, Regional, and Country level market specific insights:

  • Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for the Diabetes Assays market.
  • Competitive dynamics insights and trends provided for the Diabetes Assays market.

Understand the big picture of market performance and enhance your sales competency. Also, get an overview of the healthcare system that will help you make essential forecasts. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
    Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, ALPCO Diagnostics, Bio-Rad Laboratories Inc, DiaSorin SpA, Quidelortho Corp, Sinocare Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Siemens AG, Tosoh Corp, EKF Diagnostics Holdings Plc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

• CMO executives who must have deep understanding of the Diabetes Assays market place to make strategic planning and investment decisions.

• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on the diabetes assays market.

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

  • Develop business strategies by understanding the trends shaping and driving the diabetes assays market.

  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the diabetes assays market in the future.

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.

  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.

  • Track device sales in the global and country-specific diabetes assays market from 2015-2033.

  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Frequently asked questions

Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033 standard reports
Currency USD
$7,500

Can be used by individual purchaser only

Most Popular
$15,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$22,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Diabetes Assays reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033 in real time.

  • Access a live Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more